147 related articles for article (PubMed ID: 2075758)
1. [The entry portals and routes of Yersinia pseudotuberculosis penetration into the warm-blooded organism].
Timchenko NF; Antonenko FF
Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):15-9. PubMed ID: 2075758
[TBL] [Abstract][Full Text] [Related]
2. [The pathogenetic importance of Yersinia pseudotuberculosis lipopolysaccharide].
Kuznetsova TA; Besednova NN
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):37-41. PubMed ID: 9432844
[TBL] [Abstract][Full Text] [Related]
3. [The antibody spectrum after the inoculation of sensitive animals with Yersinia pestis and Yersinia pseudotuberculosis bacteria].
Drobkov VI; Marakulin IV; Pogorel'skiĭ IP; Darmov IV; Smirnov EV
Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):81-5. PubMed ID: 8701667
[TBL] [Abstract][Full Text] [Related]
4. Characterization of infections with wild and mutant Yersinia pseudotuberculosis strains in rabbit oral model.
Najdenski H; Vesselinova A; Golkocheva E; Garbom S; Wolf-Watz H
Adv Exp Med Biol; 2003; 529():117-20. PubMed ID: 12756740
[No Abstract] [Full Text] [Related]
5. [The immunological indices in pathology due to yersiniosis].
Voskresenskaia EA; Tseneva GIa; Alenushkina TV; Skvortsov AE
Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):68-73. PubMed ID: 9082734
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of an oral live vaccine for veterinary use against pseudotuberculosis.
Quintard B; Petit T; Ruvoen N; Carniel E; Demeure CE
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e59-65. PubMed ID: 20034670
[TBL] [Abstract][Full Text] [Related]
7. [The protective activity of Yersinia pseudotuberculosis antigens].
Tseneva GIa; Bondarenko VM; Voskresenskaia EA; Kuliashova LB
Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):45-8. PubMed ID: 7992535
[TBL] [Abstract][Full Text] [Related]
8. [The role of the outer-membrane antigens of Yersinia pseudotuberculosis in the pathogenesis and diagnosis of pseudotuberculosis].
Kuliashova LB; Tseneva GIa; Buĭnevich IuB
Zh Mikrobiol Epidemiol Immunobiol; 1997; (1):14-8. PubMed ID: 9221648
[TBL] [Abstract][Full Text] [Related]
9. Presence of Yersinia specific antibodies in hospitalized patients with arthritis and Reiter syndrome.
Constantiniu S; Chiriac R; Popovici N
Arch Roum Pathol Exp Microbiol; 1989; 48(4):341-6. PubMed ID: 2520672
[TBL] [Abstract][Full Text] [Related]
10. Lack of antibody response to invasin in humans with yersiniosis.
Fortineau N; Beretti JL; Berche P; Simonet M
Clin Diagn Lab Immunol; 1994 Mar; 1(2):235-7. PubMed ID: 7496952
[TBL] [Abstract][Full Text] [Related]
11. Th1-type immune response to infection by pYV-cured phoP-phoQ null mutant of Yersinia pseudotuberculosis is defective in mouse model.
Kumar S; Balakrishna K; Agarwal GS; Merwyn S; Rai GP; Batra HV; Sardesai AA; Gowrishankar J
Antonie Van Leeuwenhoek; 2009 Jan; 95(1):91-100. PubMed ID: 18985430
[TBL] [Abstract][Full Text] [Related]
12. Serological response of sheep to plasmid-encoded proteins of Yersinia species following natural infection with Y. enterocolitica and Y. pseudotuberculosis.
Robins-Browne RM; Bordun AM; Slee KJ
J Med Microbiol; 1993 Oct; 39(4):268-72. PubMed ID: 8411087
[TBL] [Abstract][Full Text] [Related]
13. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP.
Fisher ML; Castillo C; Mecsas J
Infect Immun; 2007 Jan; 75(1):429-42. PubMed ID: 17074849
[TBL] [Abstract][Full Text] [Related]
14. CCR2
Zhang Y; Khairallah C; Sheridan BS; van der Velden AWM; Bliska JB
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263104
[TBL] [Abstract][Full Text] [Related]
15. [The development of species-specific diagnostic preparations based on a thermostable toxin of Yersinia pseudotuberculosis].
Besednov AL; Nedashkovskaia EP; Timchenko NF
Zh Mikrobiol Epidemiol Immunobiol; 1997; (5):52-4. PubMed ID: 9432848
[No Abstract] [Full Text] [Related]
16. Responsiveness of susceptible inbred mice to Yersinia pseudotuberculosis serovar III infection.
Markova N; Nikolova S; Kussovski V; Vesselinova A; Veljanov D
Zentralbl Bakteriol; 1994 Jan; 280(3):360-70. PubMed ID: 8167430
[TBL] [Abstract][Full Text] [Related]
17. Attenuation and preserved immunogenic potential of Yersinia pseudotuberculosis mutant strains evidenced in oral pig model.
Najdenski H; Golkocheva-Markova E; Kussovski V; Vesselinova A; Garbom S; Wolf-Watz H
Zoonoses Public Health; 2009 May; 56(4):157-68. PubMed ID: 18793276
[TBL] [Abstract][Full Text] [Related]
18. [Pathogenic properties of Yersinia pseudotuberculosis in different biological models].
Timchenko NF; Isachkova LM; Shipacheva EA; Gorshkova RP; Sidorova VE
Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):43-6. PubMed ID: 6349189
[TBL] [Abstract][Full Text] [Related]
19. Precursor Abundance Influences Divergent Antigen-Specific CD8
Zhang Y; Qiu Z; Sheridan BS; Bliska JB
Infect Immun; 2021 Jul; 89(8):e0026521. PubMed ID: 34031132
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of wild mice to Yersinia pseudotuberculosis and Yersinia enterocolitica.
Fukushima H
Zentralbl Bakteriol; 1991 Oct; 275(4):530-40. PubMed ID: 1755925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]